CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

Federal regulators are caught between old-guard conservatives who demand continued mRNA funding, Rep. Massie's demand to ...

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...

The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed ...

The Trump Administration said this week it is pulling half a billion dollars from U.S. government-funded research projects to create new mRNA vaccines. Experts say this could potentially impact mRNA ...

The Department of Health and Human Services said it plans to terminate contracts and withdraw funding for certain vaccine ...

The US Department of Health and Human Services is to cancel contracts and pull funding for some vaccines that are being ...

The company reported a net loss of $825 million for the quarter. Additionally, Moderna announced a $300 million reduction at the high end of their 2025 projected revenue range due to a timing shift of ...

The U.S. Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being ...